Presentations & Publications

Recent Presentations & Publications

• Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) – January 2019

• Corporate Presentation December 2018

• Stonegate Capital Partners Research Report - August 2018

• Webcast Link to First Quarter 2018 Financial Results - May 16, 2018 at 8:30 a.m. ET

• BP1001 phase I-Ib protocol

• Drug Development and Delivery Published Article: DNA THERAPEUTICS - DNAbilize-ING Antisense

• Retail Investors Company Presentation

• Published Article: Evolution of Antisense Oligonucleotides in Oncology

• Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01

• OncLive interview with Dr. Cortes on BP-100.01 in Patients with Relapsed/Refractory AML

• Bio-Path Hopes to Blaze Profitable Path With Antisense Drugs - January 2016